International Institute For The Brain

Innovimmune is a privately-held biotechnology company based in New York, specializing in the development of novel oral small molecule immunomodulatory drugs aimed at treating cancer, autoimmune diseases, and chronic inflammation. The company is committed to advancing its innovative product pipeline through the application of cutting-edge techniques such as structure-guided drug design and artificial intelligence. With a focus on delivering first-in-class and best-in-class therapeutics, Innovimmune collaborates with leading medical experts and academic institutions to ensure rigorous research and development. The company actively seeks strategic partnerships to expedite the clinical development and commercialization of its pioneering therapeutic discoveries. Generated from the website

HCS, founded in 1995, is dedicated to supporting individuals with special challenges by offering a comprehensive range of services, including residential programs, community habilitation, and employment services. With a mission to uplift and illuminate the lives of those they touch, HCS aims to help people lead their best lives in the community of their choice. The organization prides itself on its commitment to treating every individual as a unique and precious treasure, providing invaluable guidance and support throughout their journey. With over two decades of experience, HCS fosters a thriving community that empowers families and facilitates growth and engagement for individuals with special needs. Generated from the website